Plante, M.; Garneau, L.; Laprise-Lachance, M.; Lemieux, P.; Dorval, M.
Impact of Split Dosing the First Rituximab Infusion in Patients with High Lymphocyte Count. Curr. Oncol. 2021, 28, 4118-4128.
https://doi.org/10.3390/curroncol28050349
AMA Style
Plante M, Garneau L, Laprise-Lachance M, Lemieux P, Dorval M.
Impact of Split Dosing the First Rituximab Infusion in Patients with High Lymphocyte Count. Current Oncology. 2021; 28(5):4118-4128.
https://doi.org/10.3390/curroncol28050349
Chicago/Turabian Style
Plante, Maude, Laurence Garneau, Magali Laprise-Lachance, Pierre Lemieux, and Michel Dorval.
2021. "Impact of Split Dosing the First Rituximab Infusion in Patients with High Lymphocyte Count" Current Oncology 28, no. 5: 4118-4128.
https://doi.org/10.3390/curroncol28050349
APA Style
Plante, M., Garneau, L., Laprise-Lachance, M., Lemieux, P., & Dorval, M.
(2021). Impact of Split Dosing the First Rituximab Infusion in Patients with High Lymphocyte Count. Current Oncology, 28(5), 4118-4128.
https://doi.org/10.3390/curroncol28050349